Episode Details

In this episode, we explore the latest emerging therapies for hard-to-treat uterine cancer and how they help patients with advanced or recurrent endometrial cancer.

You’ll learn:

• How targeted therapy attacks specific tumor cell features while sparing healthy tissue
•  Why do immune checkpoint inhibitors help the immune system recognize and fight cancer cells
•  How hormonal therapy slows growth in hormone-dependent endometrial carcinoma
•  The role of radiation therapy in controlling tumors in the uterus and nearby lymph nodes
•  Who benefits most from emerging therapies, including advanced-stage or recurrent cases
•  How clinical trials and FDA-approved treatments expand options for patients
•  Practical strategies to manage side effects, support immune health, and maintain quality of life

Understanding emerging therapies helps patients and families explore new treatment options when standard approaches are limited. This episode explains how specialists combine innovative therapies, monitor progress, and create personalized plans to improve outcomes.

Whether you are managing advanced endometrial cancer or supporting someone through treatment, this episode provides clear guidance on the latest therapies and how they can make a meaningful difference in care.

Blog Link: Emerging Therapies for Difficult-to-Treat Uterine Cancer

Send us Fan Mail

Thank you for listening to The Onco Life Podcast, your trusted source for expert cancer information and patient-centered education.

Author: Dr. CHRISTINA NG VAN TZE

📍 Visit us at oncolifecentre.com
📞 Call: +60 3 2242 3260
📧 Book a consultation or ask a question — we're here to support your journey.